Juno Therapeutics (JUNO) – Analyst PT Change
-
Barclays Downgrades Juno Therapeutics (JUNO) to Equalweight Following Acquisition
-
SunTrust Robinson Humphrey Downgrades Juno Therapeutics (JUNO) to Hold Following Acquisition
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to JUNO Stock Lookup